Clinical Trials Browser

Active not recruiting × OTHER_GOV × Triple Negative Breast Neoplasms × Clear all

NCT03168880 2025-04-09

TNBC

Phase 3 Active not recruiting

Triple Negative Breast Neoplasms

NCT03756298 2023-11-09

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Phase 2 Active not recruiting

Triple Negative Breast Neoplasms